---
title: "Inovio Pharma | 8-K: FY2025 Revenue: USD 65.34 K"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278936128.md"
datetime: "2026-03-12T20:13:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278936128.md)
  - [en](https://longbridge.com/en/news/278936128.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278936128.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/278936128.md) | [繁體中文](https://longbridge.com/zh-HK/news/278936128.md)


# Inovio Pharma | 8-K: FY2025 Revenue: USD 65.34 K

Revenue: As of FY2025, the actual value is USD 65.34 K.

EPS: As of FY2025, the actual value is USD -1.81, beating the estimate of USD -2.225.

EBIT: As of FY2025, the actual value is USD -89.24 M.

The provided reference, a Form 8-K filing by Inovio Pharmaceuticals, Inc., announces the issuance of a press release regarding its financial results for the quarter and full year ended December 31, 2025. However, the content of Exhibit 99.1, which would contain the actual financial and operational metrics, is not included within the given reference text. Consequently, no specific financial or operational metrics, nor any outlook or guidance for Inovio 制药 (Inovio Pharmaceuticals, Inc.), can be extracted from this document.

### Related Stocks

- [Inovio Pharmaceuticals, Inc. (INO.US)](https://longbridge.com/en/quote/INO.US.md)

## Related News & Research

- [INOVIO Announces Pricing of $17.5 Million Public Offering | INO Stock News](https://longbridge.com/en/news/281527787.md)
- [What's Behind The Drop In Inovio Pharmaceuticals Stock Today?](https://longbridge.com/en/news/281547274.md)
- [Inovio Pharmaceuticals Suspends Existing At-the-Market Stock Program](https://longbridge.com/en/news/281512814.md)
- [18:19 ETINO Deadline: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit](https://longbridge.com/en/news/281581465.md)
- [INOVIO to Participate in Upcoming Scientific Conference | INO Stock News](https://longbridge.com/en/news/281387911.md)